Glial Activation Markers in CSF and Serum From Patients With Primary Progressive Multiple Sclerosis: Potential of Serum GFAP as Disease Severity Marker?

DSpace Repository

Show simple item record

dc.contributor.author Abdelhak, Ahmed
dc.date.accessioned 2020-05-20T08:17:39Z
dc.date.available 2020-05-20T08:17:39Z
dc.date.issued 2019
dc.identifier.issn 1664-2295
dc.identifier.uri http://hdl.handle.net/10900/100814
dc.language.iso en en
dc.publisher Frontiers Media Sa de_DE
dc.relation.uri http://dx.doi.org/10.3389/fneur.2019.00280
dc.subject.ddc 610 de_DE
dc.subject.ddc 570 de_DE
dc.title Glial Activation Markers in CSF and Serum From Patients With Primary Progressive Multiple Sclerosis: Potential of Serum GFAP as Disease Severity Marker? de_DE
dc.type Artikel de_DE
utue.quellen.id 20190926111821_02080
utue.personen.roh Abdelhak, Ahmed
utue.personen.roh Hottenrott, Tilman
utue.personen.roh Morenas-Rodriguez, Estrella
utue.personen.roh Suarez-Calvet, Marc
utue.personen.roh Zettl, Uwe K.
utue.personen.roh Haass, Christian
utue.personen.roh Meuth, Sven G.
utue.personen.roh Rauer, Sebastian
utue.personen.roh Otto, Markus
utue.personen.roh Tumani, Hayrettin
utue.personen.roh Huss, Andre
dcterms.isPartOf.ZSTitelID Frontiers in Neurology de_DE
dcterms.isPartOf.ZS-Issue Article 280 de_DE
dcterms.isPartOf.ZS-Volume 10 de_DE
utue.fakultaet 04 Medizinische Fakultät


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record